Abstract: Contraception offers potential as a tool for managing certain diseases in wildlife, most notably venereally transmitted diseases or diseases transmitted at parturition. Brucellosis is an excellent example of an infectious disease present in wild populations that could potentially be managed through immunocontraception. Previous studies in bison (Bison bison) suggest that a single injection of GonaCon TM (National Wildlife Research Center, U.S. Department of Agriculture/Animal and Plant Health Inspection Service/Wildlife Services, Fort Collins, Colorado 80521, USA) results in 3 or more yr of infertility. Ongoing studies will determine if the use of GonaCon in bison decreases shedding of Brucella abortus from infected animals and will better define the duration of infertility following a single injection
BRIEF COMMUNICATION
The management of diseases in wild populations presents many challenges, including those of difficult logistics, a paucity of efficacious techniques, effective vaccine or therapeutic delivery systems, and public acceptability. Contraception offers potential as a disease management tool for certain diseases, most notably venereally transmitted diseases or diseases transmitted at parturition. Brucellosis, a group of zoonotic diseases caused by bacteria in the genus Brucella, is an excellent example of a group of infections present in wild populations that could potentially be managed through immunocontraception. Swine brucellosis, caused by Brucella suis, is transmitted through the venereal route as well as through contact with aborted fetuses and placental membranes and fluids. Bovine brucellosis, caused by Brucella abortus, is transmitted among animals, including cattle, bison (Bison bison), and elk (Cervus elaphus), primarily through contact with infected aborted fetuses, placentas, parturient fluids, or postparturient uterine discharge. Additionally, the organism is shed in the milk from infected dams and can be transmitted to calves through suckling. Following infection, females often abort. Subsequent pregnancies may result in abortion or the birth of weak or normal calves and may result in shedding of the organism. The occurrence of venereal transmission of brucellosis in bison is unknown; however, based on a single study in bison and studies in cattle, it is not considered likely to be a significant route of transmission.
1,4,5 Therefore, transmission of disease in cattle, bison, and elk is primarily dependent on the occurrence of pregnancy and abortion or calving of infected animals.
GonaCon TM (National Wildlife Research Center, U.S. Department of Agriculture/Animal and Plant Health Inspection Service/Wildlife Services, Fort Collins, Colorado 80521, USA), a gonadotropin-releasing hormone (GnRH) immunocontraceptive vaccine, is approved for use in wild white-tailed deer (Odocoileus virginianus), in which a single injection usually results in 2 or more yr of infertility.
2 This study reports the results of three small pilot studies examining the use of GonaCon to prevent parturition in bison.
The first study was conducted at Northwest Trek, a zoologic park in the state of Washington (USA). Its purpose was to determine if the GnRH vaccine had any effect on the reproductive success of five breeding-age female bison (age range: 2-8 yr) as compared to the herd's normal reproductive history of over 60% reproduction annually. The Four of the vaccinees were in mid-or late-term pregnancy when vaccinated. Results (Table 1) indicate that the vaccine did not interfere with reproductive success of animals in mid-and lateterm pregnancy at the time the vaccine was administered. More importantly, a single dose of vaccine resulted in infertility in all vaccinees for the duration of the study.
The third study, conducted from 2003 until 2008, evaluated the efficacy of GonaCon in bison at low, medium, and high doses (1,000, 2,000, and 3,000 lg, respectively). That study was conducted on bison purchased from a producer and was begun at a private ranch in Gardiner, Montana (USA). Bison were vaccinated on 20 May 2003; controls received the adjuvant only. After 2 yr, animals were moved to a private ranch in eastern South Dakota (USA). The first year of the study (2003), female bison were pastured with a bull that was later discovered to be infertile; therefore, the first exposure of the study animals to a fertile bull was summer 2004, 14 mo after vaccination. Results of that study (Table 2) indicate the vaccine had increased efficacy at the higher dose, resulting in 3 yr of infertility in three of four bison.
Two ongoing studies are designed to 1) evaluate the duration of infertility in 10 vaccinated bison that received 3,000 lg GonaCon as compared to 10 controls in a range setting; and 2) determine if the use of GonaCon decreases shedding of B. abortus from a group of 14 naturally infected bison during the calving season as compared to a similar group of nonvaccinees. If these studies confirm the safety and efficacy of GonaCon in bison and demonstrate its utility in reducing shedding of B. abortus, the vaccine could provide a potential nonlethal management tool to prevent transmission of the disease in an infected bison population. 
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